scispace - formally typeset
M

Mohammad Adil

Researcher at Bharati Vidyapeeth University

Publications -  34
Citations -  694

Mohammad Adil is an academic researcher from Bharati Vidyapeeth University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 18 publications receiving 561 citations. Previous affiliations of Mohammad Adil include Hamdard University.

Papers
More filters
Journal ArticleDOI

Ameliorative effect of berberine against gentamicin-induced nephrotoxicity in rats via attenuation of oxidative stress, inflammation, apoptosis and mitochondrial dysfunction

TL;DR: Berberine exerts renoprotective effects through its anti-oxidant, anti-inflammatory, and anti-apoptotic properties through the protective effect of berberine against GM-induced nephrotoxicity and possible underlying mechanisms.
Journal ArticleDOI

Naringin ameliorates sodium arsenite-induced renal and hepatic toxicity in rats: decisive role of KIM-1, Caspase-3, TGF-β, and TNF-α.

TL;DR: Naringin treatment ameliorates arsenic-induced renal and hepatic damage in rats due its antioxidant and anti-inflammatory properties via down-regulation of elevated oxido-nitrosative stress, KIM-1, Caspase-3, TGF-β, and TNF-α levels.
Journal ArticleDOI

Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats.

TL;DR: It is proposed that naringin has an anti-inflammatory, anti-oxidant and anti-apoptotic potential effect at colorectal sites as it modulates the production and expression of oxidative mediators such as MDA, MPO, NO and XO, thus reducing DNA damage.
Journal ArticleDOI

Ameliorative effect of naringin in acetaminophen-induced hepatic and renal toxicity in laboratory rats: role of FXR and KIM-1

TL;DR: Naringin exerts its hepato- and nephroprotective effect via modulation of oxido-nitrosative stress, FXR and KIM-1 mRNA expression as well as reduced histological alteration induced by APAP in the liver and kidney.
Journal ArticleDOI

Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies

TL;DR: Results from the preclinical and clinical studies convey conflicting findings over insulin safety profile on bone health, and evidence from animal studies suggest that incretin-based therapy have anabolic effect on bone suggests a neutral effect on the bone health and risk of fracture.